Hims stock jumps after RFK Jr. opens access to some unapproved peptides
Investor's Business Daily reports Hims shares rose Wednesday after RFK Jr. went around the FDA to allow certain unapproved peptides.
Recap by typeshit. Full story at Investor's Business Daily on MSN.